Login / Signup

Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.

Mohammad Mahbubul HoqueYuichi IidaHitoshi KotaniMamoru Harada
Published in: Cancer reports (Hoboken, N.J.) (2024)
Together, our results indicate that sequential treatment with GEM and senolytic drugs effectively kill human pancreatic cancer cells.
Keyphrases
  • endothelial cells
  • high glucose
  • induced pluripotent stem cells
  • pluripotent stem cells
  • radiation therapy
  • oxidative stress
  • locally advanced
  • rectal cancer